Development and validation of a risk prediction model for interstitial lung disease in patients with rheumatoid arthritis

The developed risk prediction model for RA-ILD demonstrates high predictive ability and clinical utility. It may assist in assessing the risk of ILD in patients with RA, thereby facilitating clinical risk stratification and informing quantitative diagnostic approaches.